Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls
© 2023. Springer Nature Limited..
We aimed to compare longitudinal brain atrophy in patients with neuromyelitis optica spectrum disorder (NMOSD) with healthy controls (HCs). The atrophy rate in patients with anti-aquaporin-4 antibody-positive NMOSD (AQP4 + NMOSD) was compared with age-sex-matched HCs recruited from the Japanese Alzheimer's Disease Neuroimaging Initiative study and another study performed at Chiba University. Twenty-nine patients with AQP4 + NMOSD and 29 HCs were enrolled in the study. The time between magnetic resonance imaging (MRI) scans was longer in the AQP4 + NMOSD group compared with the HCs (median; 3.2 vs. 2.9 years, P = 0.009). The annualized normalized white matter volume (NWV) atrophy rate was higher in the AQP4 + NMOSD group compared with the HCs (median; 0.37 vs. - 0.14, P = 0.018). The maximum spinal cord lesion length negatively correlated with NWV at baseline MRI in patients with AQP4 + NMOSD (Spearman's rho = - 0.41, P = 0.027). The annualized NWV atrophy rate negatively correlated with the time between initiation of persistent prednisolone usage and baseline MRI in patients with AQP4 + NMOSD (Spearman's rho = - 0.43, P = 0.019). Patients with AQP4 + NMOSD had a greater annualized NWV atrophy rate than HCs. Suppressing disease activity may prevent brain atrophy in patients with AQP4 + NMOSD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Scientific reports - 13(2023), 1 vom: 03. Aug., Seite 12631 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Masuda, Hiroki [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aquaporin 4 |
---|
Anmerkungen: |
Date Completed 07.08.2023 Date Revised 21.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41598-023-38893-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360369413 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360369413 | ||
003 | DE-627 | ||
005 | 20231226210725.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41598-023-38893-1 |2 doi | |
028 | 5 | 2 | |a pubmed24n1201.xml |
035 | |a (DE-627)NLM360369413 | ||
035 | |a (NLM)37537208 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Masuda, Hiroki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.08.2023 | ||
500 | |a Date Revised 21.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. Springer Nature Limited. | ||
520 | |a We aimed to compare longitudinal brain atrophy in patients with neuromyelitis optica spectrum disorder (NMOSD) with healthy controls (HCs). The atrophy rate in patients with anti-aquaporin-4 antibody-positive NMOSD (AQP4 + NMOSD) was compared with age-sex-matched HCs recruited from the Japanese Alzheimer's Disease Neuroimaging Initiative study and another study performed at Chiba University. Twenty-nine patients with AQP4 + NMOSD and 29 HCs were enrolled in the study. The time between magnetic resonance imaging (MRI) scans was longer in the AQP4 + NMOSD group compared with the HCs (median; 3.2 vs. 2.9 years, P = 0.009). The annualized normalized white matter volume (NWV) atrophy rate was higher in the AQP4 + NMOSD group compared with the HCs (median; 0.37 vs. - 0.14, P = 0.018). The maximum spinal cord lesion length negatively correlated with NWV at baseline MRI in patients with AQP4 + NMOSD (Spearman's rho = - 0.41, P = 0.027). The annualized NWV atrophy rate negatively correlated with the time between initiation of persistent prednisolone usage and baseline MRI in patients with AQP4 + NMOSD (Spearman's rho = - 0.43, P = 0.019). Patients with AQP4 + NMOSD had a greater annualized NWV atrophy rate than HCs. Suppressing disease activity may prevent brain atrophy in patients with AQP4 + NMOSD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Autoantibodies |2 NLM | |
650 | 7 | |a Aquaporin 4 |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a Myelin-Oligodendrocyte Glycoprotein |2 NLM | |
700 | 1 | |a Mori, Masahiro |e verfasserin |4 aut | |
700 | 1 | |a Hirano, Shigeki |e verfasserin |4 aut | |
700 | 1 | |a Uzawa, Akiyuki |e verfasserin |4 aut | |
700 | 1 | |a Uchida, Tomohiko |e verfasserin |4 aut | |
700 | 1 | |a Muto, Mayumi |e verfasserin |4 aut | |
700 | 1 | |a Ohtani, Ryohei |e verfasserin |4 aut | |
700 | 1 | |a Aoki, Reiji |e verfasserin |4 aut | |
700 | 1 | |a Hirano, Yoshiyuki |e verfasserin |4 aut | |
700 | 0 | |a Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) |e verfasserin |4 aut | |
700 | 1 | |a Kuwabara, Satoshi |e verfasserin |4 aut | |
700 | 1 | |a Iwatsubo, Takeshi |e investigator |4 oth | |
700 | 1 | |a Asada, Takashi |e investigator |4 oth | |
700 | 1 | |a Arai, Hiroyuki |e investigator |4 oth | |
700 | 1 | |a Sugishita, Morihiro |e investigator |4 oth | |
700 | 1 | |a Matsuda, Hiroshi |e investigator |4 oth | |
700 | 1 | |a Ito, Kengo |e investigator |4 oth | |
700 | 1 | |a Senda, Michio |e investigator |4 oth | |
700 | 1 | |a Ishii, Kenji |e investigator |4 oth | |
700 | 1 | |a Kuwano, Ryozo |e investigator |4 oth | |
700 | 1 | |a Ikeuchi, Takeshi |e investigator |4 oth | |
700 | 1 | |a Sato, Noriko |e investigator |4 oth | |
700 | 1 | |a Sato, Hajime |e investigator |4 oth | |
700 | 1 | |a Shimohama, Shun |e investigator |4 oth | |
700 | 1 | |a Saitoh, Masaki |e investigator |4 oth | |
700 | 1 | |a Yamauchi, Rika |e investigator |4 oth | |
700 | 1 | |a Hayashi, Takashi |e investigator |4 oth | |
700 | 1 | |a Kobayashi, Seiju |e investigator |4 oth | |
700 | 1 | |a Nakano, Norihito |e investigator |4 oth | |
700 | 1 | |a Kanazawa, Junichiro |e investigator |4 oth | |
700 | 1 | |a Ando, Takeshi |e investigator |4 oth | |
700 | 1 | |a Takanami, Chiyoko |e investigator |4 oth | |
700 | 1 | |a Hareyama, Masato |e investigator |4 oth | |
700 | 1 | |a Hatakenaka, Masamitsu |e investigator |4 oth | |
700 | 1 | |a Tsukamoto, Eriko |e investigator |4 oth | |
700 | 1 | |a Ochi, Shinji |e investigator |4 oth | |
700 | 1 | |a Shoji, Mikio |e investigator |4 oth | |
700 | 1 | |a Matsubara, Etsuro |e investigator |4 oth | |
700 | 1 | |a Kawarabayashi, Takeshi |e investigator |4 oth | |
700 | 1 | |a Wakasaya, Yasuhito |e investigator |4 oth | |
700 | 1 | |a Nakata, Takashi |e investigator |4 oth | |
700 | 1 | |a Nakahata, Naoko |e investigator |4 oth | |
700 | 1 | |a Ono, Shuichi |e investigator |4 oth | |
700 | 1 | |a Takai, Yoshihiro |e investigator |4 oth | |
700 | 1 | |a Takahashi, Satoshi |e investigator |4 oth | |
700 | 1 | |a Yonezawa, Hisashi |e investigator |4 oth | |
700 | 1 | |a Takahashi, Junko |e investigator |4 oth | |
700 | 1 | |a Kudoh, Masako |e investigator |4 oth | |
700 | 1 | |a Sasaki, Makoto |e investigator |4 oth | |
700 | 1 | |a Matsumura, Yutaka |e investigator |4 oth | |
700 | 1 | |a Hirata, Yohsuke |e investigator |4 oth | |
700 | 1 | |a Metoki, Tsuyoshi |e investigator |4 oth | |
700 | 1 | |a Hayakawa, Susumu |e investigator |4 oth | |
700 | 1 | |a Sato, Yuichi |e investigator |4 oth | |
700 | 1 | |a Takeda, Masayuki |e investigator |4 oth | |
700 | 1 | |a Sasaki, Toshiaki |e investigator |4 oth | |
700 | 1 | |a Sera, Koichiro |e investigator |4 oth | |
700 | 1 | |a Terasaki, Kazunori |e investigator |4 oth | |
700 | 1 | |a Saitoh, Yoshihiro |e investigator |4 oth | |
700 | 1 | |a Goto, Shoko |e investigator |4 oth | |
700 | 1 | |a Ueno, Kuniko |e investigator |4 oth | |
700 | 1 | |a Sakashita, Hiromi |e investigator |4 oth | |
700 | 1 | |a Watanabe, Kuniko |e investigator |4 oth | |
700 | 1 | |a Nagata, Ken |e investigator |4 oth | |
700 | 1 | |a Sato, Yuichi |e investigator |4 oth | |
700 | 1 | |a Maeda, Tetsuya |e investigator |4 oth | |
700 | 1 | |a Kondoh, Yasushi |e investigator |4 oth | |
700 | 1 | |a Yamazaki, Takashi |e investigator |4 oth | |
700 | 1 | |a Takano, Daiki |e investigator |4 oth | |
700 | 1 | |a Miyata, Mio |e investigator |4 oth | |
700 | 1 | |a Komatsu, Hiromi |e investigator |4 oth | |
700 | 1 | |a Watanabe, Mayumi |e investigator |4 oth | |
700 | 1 | |a Sinoda, Tomomi |e investigator |4 oth | |
700 | 1 | |a Muraoka, Rena |e investigator |4 oth | |
700 | 1 | |a Kikuchi, Kayoko |e investigator |4 oth | |
700 | 1 | |a Ito, Hitomi |e investigator |4 oth | |
700 | 1 | |a Sato, Aki |e investigator |4 oth | |
700 | 1 | |a Kinoshita, Toshibumi |e investigator |4 oth | |
700 | 1 | |a Toyoshima, Hideyo |e investigator |4 oth | |
700 | 1 | |a Sato, Kaoru |e investigator |4 oth | |
700 | 1 | |a Sugawara, Shigeki |e investigator |4 oth | |
700 | 1 | |a Ito, Isao |e investigator |4 oth | |
700 | 1 | |a Kumagai, Fumiko |e investigator |4 oth | |
700 | 1 | |a Furukawa, Katsutoshi |e investigator |4 oth | |
700 | 1 | |a Waragai, Masaaki |e investigator |4 oth | |
700 | 1 | |a Tomita, Naoki |e investigator |4 oth | |
700 | 1 | |a Okamura, Nobuyuki |e investigator |4 oth | |
700 | 1 | |a Ootsuki, Mari |e investigator |4 oth | |
700 | 1 | |a Sugawara, Katsumi |e investigator |4 oth | |
700 | 1 | |a Sugawara, Satomi |e investigator |4 oth | |
700 | 1 | |a Mugikura, Shunji |e investigator |4 oth | |
700 | 1 | |a Umetsu, Atsushi |e investigator |4 oth | |
700 | 1 | |a Murata, Takanori |e investigator |4 oth | |
700 | 1 | |a Nagasaka, Tatsuo |e investigator |4 oth | |
700 | 1 | |a Kudo, Yukitsuka |e investigator |4 oth | |
700 | 1 | |a Tashiro, Manabu |e investigator |4 oth | |
700 | 1 | |a Watanuki, Shoichi |e investigator |4 oth | |
700 | 1 | |a Nishizawa, Masatoyo |e investigator |4 oth | |
700 | 1 | |a Tokutake, Takayoshi |e investigator |4 oth | |
700 | 1 | |a Ishikawa, Saeri |e investigator |4 oth | |
700 | 1 | |a Kishida, Emiko |e investigator |4 oth | |
700 | 1 | |a Sato, Nozomi |e investigator |4 oth | |
700 | 1 | |a Hagiwara, Mieko |e investigator |4 oth | |
700 | 1 | |a Yamanaka, Kumi |e investigator |4 oth | |
700 | 1 | |a Watanabe, Takeyuki |e investigator |4 oth | |
700 | 1 | |a Takasugi, Taeko |e investigator |4 oth | |
700 | 1 | |a Inagawa, Shoichi |e investigator |4 oth | |
700 | 1 | |a Naito, Kenichi |e investigator |4 oth | |
700 | 1 | |a Awaji, Masanori |e investigator |4 oth | |
700 | 1 | |a Kanazawa, Tsutomu |e investigator |4 oth | |
700 | 1 | |a Okamoto, Kouiti |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 13(2023), 1 vom: 03. Aug., Seite 12631 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:03 |g month:08 |g pages:12631 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-023-38893-1 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2023 |e 1 |b 03 |c 08 |h 12631 |